8:00 – 8:45 a.m.
Basic Principles of Cancer ImmunityAbul Abbas, MD – University of California, San Francisco
8:45– 8:50 a.m.
Break
8:50 – 9:30 a.m.
Vaccination Strategies, Identification of NeoantigensGerald Linette, MD, PhD – University of Pennsylvania
9:30 – 9:35 a.m.
9:35 – 10:15 a.m.
The Tumor MicroenvironmentGregory Beatty, MD, PhD – University of Pennsylvania
10:15 – 10:20 a.m.
10:20 – 11:00 a.m.
Checkpoint Blockade Therapy: Current Status, BiomarkersIra Mellman, PhD – Genentech
11:00 – 11:05 a.m.
11:05 – 1145 a.m.
Next Generation Checkpoint and Combination TherapiesIra Mellman, PhD – Genentech
1145 a.m. – 12:45 p.m.
Lunch
12:45 – 1:25 p.m.
Immune-Related Toxicity: Mechanisms and ManagementKevan Herold, MD – Yale University
1:25 – 1:30 p.m.
1:30 – 2:10 p.m.
CAR-T Cell Therapy: Principles and Current Practices
Mark Leick, MD, PGY-7 – Harvard University
2:10 – 2:15 p.m.
2:15 – 2:55 p.m.
CAR-T Cell Therapy: Next Generation CARs, Toxicities, Challenges and ProspectsCarl June, MD – University of Pennsylvania
2:55 – 3:00 p.m.
3:00 – 3:40 p.m.
Adoptive T Cell-Based Therapies: more than CAR-TDaniel Powell, MD, PhD – University of Pennsylvania
3:40 – 3:45 p.m.
3:45 – 4:25 p.m.
Next Generation StrategiesKole Roybal, PhD – University of California, San Francisco
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us